Challenges in using signs and symptoms to evaluate new biomarkers of dry eye disease.
From TearLab Corporation, San Diego, CA. Electronic address: bdsulliv@TearLab.com.
Benjamin
B
Sullivan
D015415:Biomarkers / Q000378:metabolism; D003316:Corneal Diseases / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy; D015352:Dry Eye Syndromes / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy; D006801:Humans; D009885:Ophthalmology / Q000379:methods / Q000639:trends*; D009994:Osmolar Concentration; D013666:Tears / Q000378:metabolism*
D015415:Biomarkers